Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole]

Details Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole] Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole]

C - Chemistry, Metallurgy

07

D

C07D 471/20 (2006.01) A61K 31/438 (2006.01) A61P 3/04 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2274204

The present invention relates to compounds of the general formula (see formula I) wherein the substituents are described in the application and to pharmaceutically acceptable acid addition salts thereof. The compound of the invention are useful in the treatment of diseases related to the orphanin FQ (OFQ) receptor, which include psychiatric, neurological and physiological disorders, such as anxiety and stress disorders, depression, trauma, memory loss due to Alzheimer's disease or other dementias, deficits in cognition and learning, epilepsy and convulsions, acute and/or chronic pain conditions, and symptoms of addictive drug withdrawal, control of water balance, Na+ excretion, arterial blood pressure disorders and metabolic disorders such as obesity.

Affiliated with

Also associated with

Rating

Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole] does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole], we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole] will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2037514